EyePoint Pharmaceuticals Inc

NASDAQ:EYPT 4:00:00 PM EDT

16.16

-0.31 (-1.88%)

5:13:05 PM EDT: $15.85 -0.31 (-1.90%)

Market Cap (Intraday)	805.28M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$9.78 Million
Adjusted EPS	-$0.39

See more estimates

10-Day MA	$18.26
50-Day MA	$22.86
200-Day MA	$16.15

See more pivots

EyePoint Pharmaceuticals Inc Stock, NASDAQ:EYPT

480 Pleasant Street, Suite A-210, Watertown, Massachusetts 02472

United States of America

Phone: +1.617.926.5000

Number of Employees: 121

http://www.eyepointpharma.com

Description

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.